These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9633795)

  • 1. Increased tissue neutral endopeptidase 24.11 activity in spontaneously hypertensive hamsters.
    Vishwanatha JK; Davis RG; Blumberg S; Gao XP; Rubinstein I
    Am J Hypertens; 1998 May; 11(5):585-90. PubMed ID: 9633795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats.
    Schulz R; Sakane Y; Berry C; Ghai R
    J Enzyme Inhib; 1991; 4(4):347-58. PubMed ID: 1669834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters.
    Rubinstein I; Houmsse M; Davis RG; Vishwanatha JK
    Biochem Biophys Res Commun; 1992 Mar; 183(3):1117-23. PubMed ID: 1314575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen on neprilysin expression in uterus and kidney of Sprague-Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats.
    Neves LA; Chappell MC; Ferrario CM; Gallagher PE; Ganten D; Brosnihan KB
    Peptides; 2006 Nov; 27(11):2912-8. PubMed ID: 16890325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
    Dalzell JR; Seed A; Berry C; Whelan CJ; Petrie MC; Padmanabhan N; Clarke A; Biggerstaff F; Hillier C; McMurray JJ
    Cardiovasc Ther; 2014 Feb; 32(1):13-8. PubMed ID: 24138103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH- and time-dependent inhibition of rat kidney neutral endoprotease 24.11 by thiorphan and phosphoramidon.
    Jeng AY; Ansell J; Erion MD
    Life Sci; 1989; 45(22):2109-14. PubMed ID: 2601566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ.
    Suzuki H; Gao XP; Olopade CO; Rubinstein I
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R393-7. PubMed ID: 8770140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase.
    Dickinson KE; Tymiak AA; Cohen RB; Liu EC; Webb ML; Hedberg A
    Biochem Biophys Res Commun; 1991 Apr; 176(1):423-30. PubMed ID: 2018530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.
    Stasch JP; Hirth-Dietrich C; Ganten D; Wegner M
    Am J Hypertens; 1996 Aug; 9(8):795-802. PubMed ID: 8862226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGH(2)-TxA(2)-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension.
    Suzuki H; Ikezaki H; Hong D; Rubinstein I
    J Appl Physiol (1985); 2000 Jun; 88(6):1983-8. PubMed ID: 10846009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
    Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV; Sansom CE; Turner AJ
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of spontaneously hypertensive rats.
    Jiang W; Jiang HF; Pan CS; Cai DY; Qi YF; Pang YZ; Tang CS
    Hypertens Res; 2004 Feb; 27(2):109-17. PubMed ID: 15005274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading.
    Aviv R; Gurbanov K; Hoffman A; Blumberg S; Winaver J
    Kidney Int; 1995 Mar; 47(3):855-60. PubMed ID: 7752584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble recombinant neprilysin induces aggrecanase-mediated cleavage of aggrecan in cartilage explant cultures.
    Chevrier A; Mort JS; Crine P; Hoemann CD; Buschmann MD
    Arch Biochem Biophys; 2001 Dec; 396(2):178-86. PubMed ID: 11747295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M; Hirth-Dietrich C; Stasch JP
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans.
    Jalil JE; Ocaranza MP; Oliveri C; Córdova S; Godoy I; Chamorro G; Braun S; Fardella C; Michel JB; Lavandero S
    J Hum Hypertens; 2004 Feb; 18(2):119-25. PubMed ID: 14730327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.